IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Phasebio Pharmaceuticals Inc

CUSIP: 717224109 | 148 institutional holders

Quarters

Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2022

Dafna Capital Management LLC321,856
0.0% of portfolio›$9.7K
Acadian Asset Management LLC172,958
0.0% of portfolio›$4
Hamilton Lane Advisors LLC34,208
0.0% of portfolio›$1
IPG Investment Advisors LLC28,700
0.0% of portfolio›$864
Barclays PLC197
0.0% of portfolio›$6
StyleTurnoverLocationFiled
Dafna Capital Management LLC
321,856$9.7K0.0%ValueMediumLos Angeles, CA2023-02-14
Acadian Asset Management LLC
172,958$40.0%GARPMediumBoston, MA2023-02-14
Hamilton Lane Advisors LLC
34,208$10.0%YieldMediumConshohocken, PA2023-02-09
IPG Investment Advisors LLC
28,700$8640.0%CoreMediumSan Diego, CA2023-02-14
Barclays PLC
197$60.0%CoreMediumLondon, United Kingdom2026-03-30